Second-line nab-paclitaxel for advanced urothelial carcinoma

被引：2
|
作者：
Sarah Payton
机构：
来源：
Nature Reviews Urology | 2013年 / 10卷 / 8期
关键词：
D O I：
10.1038/nrurol.2013.131
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 431
相关论文
共 50 条
  • [1] Nab-paclitaxel as second-line treatment in advanced biliary cancer
    Unseld, M.
    Kornek, G.
    Werner, S.
    Guenther, S.
    Christoph, Z.
    Gerald, P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S431 - S432
  • [2] Nab-paclitaxel as second-line treatment in advanced biliary cancer.
    Prager, Gerald W.
    Kornek, Gabriela
    Scheithauer, Werner
    Steger, Guenther G.
    Zielinski, Christoph
    Unseld, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [3] A phase II study of single-agent nab-paclitaxel as second-line therapy in patients with metastatic urothelial carcinoma
    Sridhar, S. S.
    Canil, C. M.
    Mukherjee, S. D.
    Winquist, E.
    Elser, C.
    Eisen, A.
    Chung, A.
    Ko, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Combination of Gemcitabine and Paclitaxel as Second-line Chemotherapy for Advanced Urothelial Carcinoma
    Suyama, Takahito
    Ueda, Takeshi
    Fukasawa, Satoshi
    Imamura, Yusuke
    Nakamura, Kazuyoshi
    Miyasaka, Kyoko
    Sazuka, Tomokazu
    Egoshi, Ken-ichi
    Nihei, Naoki
    Hamano, Masaaki
    Ichikawa, Tomohiko
    Maruoka, Masayuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (04) : 244 - 250
  • [5] A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer
    Hosein, Peter J.
    Lopes, Gilberto de Lima, Jr.
    Pastorini, Vitor H.
    Gomez, Christina
    Macintyre, Jessica
    Zayas, Gloria
    Reis, Isildinha
    Montero, Alberto J.
    Merchan, Jaime R.
    Lima, Caio M. Rocha
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (02): : 151 - 156
  • [6] Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinoma
    An, Xin
    Xue, Cong
    Chen, Meiting
    Ni, Mengqian
    Ma, Huali
    Tian, Li
    Huang, Riqing
    Li, Xiangdong
    Ye, Yunlin
    Qin, Tao
    Dong, Pei
    Li, Zhiyong
    Peng, Jing
    Yao, Kai
    Zhou, Fangjian
    Liu, Zhuowei
    Shi, Yanxia
    BJU INTERNATIONAL, 2024, 134 (01) : 63 - 71
  • [7] FOLFIRINOX and gemcitabine plus nab-paclitaxel as second-line or later chemotherapy and for locally advanced disease
    Maeda, Osamu
    Yokoyama, Yukihiro
    Ando, Yuichi
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma
    Matsumoto, Kazumasa
    Irie, Akira
    Satoh, Takefumi
    Okazaki, Miyoko
    Iwamura, Masatsugu
    Baba, Shiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (11) : 1000 - 1004
  • [9] Nab-paclitaxel plus ramucirumab combination therapy as second-line with advanced gastric cancer:Retrospective study
    Kashiwada, Tomomi
    Nishioka, Atsujiro
    Komiya, Kazutoshi
    Aragane, Naoko
    Kimura, Shinya
    ANNALS OF ONCOLOGY, 2019, 30 : 140 - 140
  • [10] Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer
    Fukuchi, Minoru
    Mochiki, Erito
    Ishiguro, Toru
    Ogura, Toshiro
    Sobajima, Jun
    Kumagai, Youichi
    Ishibashi, Keiichiro
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2016, 36 (12) : 6699 - 6703
12345